OverviewChartNewsTraderScreen

BNP Paribas Knock-Out 4AB/  DE000PF3WV22  /

EUWAX
2024-04-23  8:54:31 AM Chg.+0.02 Bid9:18:08 AM Ask9:18:08 AM Underlying Strike price Expiration date Option type
6.18EUR +0.32% 6.18
Bid Size: 3,000		 6.24
Ask Size: 3,000		 ABBVIE INC. D... 102.9075 - 2078-12-31 Call
GlobeNewswire 04-22 TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire 04-22 Anthos Therapeutics Announces Appointment of Bill Meury as CEO
GlobeNewswire 04-19 NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes a...
GlobeNewswire 04-19 Life Science Cares Launches in Switzerland
GlobeNewswire 04-19 Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
GlobeNewswire 04-19 Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...
GlobeNewswire 04-18 Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial fo...
GlobeNewswire 04-17 Royalty Pharma Declares Second Quarter 2024 Dividend
GlobeNewswire 04-16 Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
GlobeNewswire 04-16 OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of C...
GlobeNewswire 04-16 Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
GlobeNewswire 04-15 Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessi...
Newsfile Corp 04-12 Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Acce...
GlobeNewswire 04-09 STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – DOMA, LABP, FUSN, ...
GlobeNewswire 04-09 Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
GlobeNewswire 04-08 Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual ...
GlobeNewswire 04-08 CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Dire...
GlobeNewswire 04-06 Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Ca...
GlobeNewswire 04-03 Sig Kirk Joins Assertio Board of Directors
GlobeNewswire 04-02 Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over P...
GlobeNewswire 04-02 Abivax reports 2023 financial results and operational update
GlobeNewswire 04-02 OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1...
GlobeNewswire 04-01 SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ADTH, LABP, FUSN
GlobeNewswire 04-01 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire 04-01 NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year